Amid a viral social media trend glorifying the halcyon days of 2016, Novo Nordisk has gone back an extra decade to find ...

People using weight loss drugs such as Ozempic have been complaining of an unusual impact it has been having on the ...

Novo Nordisk is worried about competition and wants to be seen as the cool kid... by using a 20-year-old ad format.

New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...

Low energy and “Ozempic face” can be the downsides for people on GLP-1s, the increasingly popular drugs that go by the names Ozemic, Wegovy and Mounjaro.

Novo Nordisk’s new Ozempic ads star Justin Long and John Hodgman, the “Mac” and “PC” of an iconic Apple campaign, to promote the drug’s wider FDA approvals.

Glucagon-like peptide-1 receptor agonist drugs (commonly referred to as GLP-1 agonists) have become widely prescribed for ...

During President Donald Trump's roundtable on rural health care, he started roasting his 'very, very rich' friend who he says ...

New research suggests that people using next-generation weight loss drugs may be losing weight without the nutritional ...

With more and more Americans using weight loss medications, many restaurants are looking to adapt, providing more options ...